Immunocore Holdings (IMCR) Return on Capital Employed (2022 - 2026)
Immunocore Holdings (IMCR) posted quarterly Return on Capital Employed of 4.15% for Q1 2026, up 132.0% year-on-year from 1.79% in Q1 2025, and up 23.24% on a QoQ basis from 5.41% in Q4 2025.
Immunocore Holdings (IMCR) Return on Capital Employed (2022 - 2026) Analysis & Trends
Immunocore Holdings (IMCR) has reported Return on Capital Employed for 4 consecutive years, with 4.15% the latest figure, recorded in Q1 2026.
- Quarterly Return on Capital Employed rose 132.0% year-over-year to 4.15% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.15% (up 132.0% YoY) and the FY2025 annual result came in at 5.73%, up 619.0% from the prior year.
- Return on Capital Employed rose to 4.15% in Q1 2026 per IMCR's latest filing, from 5.41% in the prior quarter.
- Over the last five years, Return on Capital Employed for IMCR reached as high as 4.15% in Q1 2026 and fell as low as 21.58% in Q4 2022.
- A 4-year average of 8.49% and a median of 6.96% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2025 — Return on Capital Employed soared 662 bps — and 2026, when it jumped 132 bps.
- Year by year, Return on Capital Employed stood at 21.58% in 2022, then soared by 61 bps to 8.44% in 2024, then jumped by 36 bps to 5.41% in 2025, then grew by 23 bps to 4.15% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 4.15%, 5.41%, and 4.89% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Immunocore Holdings | 1.80 Bn | 957.43 Mn | 106.24 Mn | -4.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.15% |
| Dec 31, 2025 | -5.41% |
| Sep 30, 2025 | -4.89% |
| Jun 30, 2025 | -5.25% |
| Mar 31, 2025 | -5.47% |
| Dec 31, 2024 | -8.44% |
| Sep 30, 2024 | -8.64% |
| Jun 30, 2024 | -8.95% |
| Mar 31, 2024 | -12.09% |
| Dec 31, 2022 | -21.58% |